Keywords: zonagen, gets, irb, appro, ph, iii, androxal

Zonagen gets IRB appro for Ph III Androxal trial

Article | 16 January 2006

Print This

US drugmaker Zonagen has received Investigational Review Board approval for the start of its Phase III study of Androxal, a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in